




Testing the effectiveness of a self-efficacy based exercise intervention for inactive
people with type 2 diabetes mellitus








Publisher's PDF, also known as Version of record
Link to publication in Tilburg University Research Portal
Citation for published version (APA):
van der Heijden, M. M. P., Pouwer, F., Romeijnders, A. C., & Pop, V. J. M. (2012). Testing the effectiveness of a
self-efficacy based exercise intervention for inactive people with type 2 diabetes mellitus: Design of a controlled
clinical trial. BMC Public Health, 12, [331]. https://doi.org/10.1186/1471-2458-12-331
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 12. May. 2021
van der Heijden et al. BMC Public Health 2012, 12:331
http://www.biomedcentral.com/1471-2458/12/331STUDY PROTOCOL Open AccessTesting the effectiveness of a self-efficacy based
exercise intervention for inactive people with
type 2 diabetes mellitus: design of a controlled
clinical trial
Marion MP van der Heijden1, François Pouwer1*, Arnold C Romeijnders2 and Victor JM Pop1Abstract
Background: Sufficient exercise is important for people with Type 2 Diabetes Mellitus (T2DM), as it can prevent future
health problems. Despite, it is estimated that only 30-40% of people with T2DM are sufficiently active. One of the
psychosocial constructs that is believed to influence physical activity behaviour, is exercise self-efficacy. The goal of this
study is to evaluate a patient-tailored exercise intervention for people with T2DM that takes exercise self-efficacy into
account.
Methods/Design: This study is conducted as a non-randomized controlled clinical trial. Patients are eligible when they
are diagnosed with T2DM, exercise less than advised in the ADA guideline of 150 min/week of moderate-intensity aerobic
physical activity, have an BMI >25 and are between 18 and 80 years old. Recruitment takes place at a Primary care
organization of general practitioners and practice nurses in the south of the Netherlands.
Participants are allocated to three groups: An advice intervention -for participants with a high exercise self-efficacy score- in
which participants receive a patient-tailored exercise intervention, an intensive intervention -for participants with a low
exercise self-efficacy score- in which participants receive a patient-tailored exercise intervention accomplished by a group
based intervention, and a control group in which participants receive regular Dutch diabetes care. The primary outcome
measure of this study is physical activity. Secondary outcome measures are health status, (symptoms of) depression,
exercise self-efficacy, Body Mass Index (BMI), blood pressure and glycemic control.
Discussion: We aimed to design an intervention that can be implemented in Primary care, but also to design an easy
accessible program. This study is innovative as it is -to our best knowledge- the first study that takes level of exercise
self-efficacy of people with T2DM into account by means of giving extra support to those with the lowest exercise
self-efficacy. If the program succeeds in increasing the amount of physical activity it can be implemented in regular
primary care.
Trial registration: Dutch Trial Register NTR2734* Correspondence: F.Pouwer@uvt.nl
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Diabetes mellitus is a chronic, metabolic disorder charac-
terized by hyperglycemia as a result of a defect in insulin
secretion and/or insulin resistance [1]. In 2000 the
worldwide prevalence of diabetes mellitus was 171 mil-
lion. This is expected to increase up to 366 million in
2030 [2]. Approximately 90% of the people with diabetes
mellitus have type 2 diabetes mellitus (T2DM) [3].
T2DM often results in (severe) micro- and macro-
vascular complications, such as cardiovascular problems,
retinopathy, neuropathy and kidney failure [1]. Approxi-
mately 72% of the people with T2DM have at least one of
these complications [4]. Besides the burden for the patient,
this also imposes a burden on the health care system: people
with one or more micro- and/or macro vascular T2DM
complication(s) cost 70-350% as much a year compared to
patients without T2DM complications [4]. In addition, glo-
bal mortality attributable to diabetes was estimated to be
2.9 million people in 2000, 5.2% of all deaths [5].
Physical inactivity is one of the major risk factors for
T2DM and related complications, independent of body
mass index (BMI) [6-8]. Increasing physical activity
reduces the risk for T2DM and its complications by en-
hancing metabolic control. Moreover, appropriate levels of
physical activity are associated with increased cardio-
respiratory fitness, increased health related quality of life
and a reduced risk of total- and cardiovascular mortality
[9-11]. The American Diabetes Association advises people
with T2DM to have at least 150 min/week of moderate-
intensity aerobic physical activity (50–70% of maximum
heart rate) to maximize the effects of physical activity. In
addition, resistance training should be performed three
times per week in the absence of contraindications [12].
Because of its beneficial effects, achieving and/or main-
taining an appropriate level of exercise is an important goal
in diabetes management [12]. Despite, it is estimated that
only 30-40% of people with T2DM are sufficiently active
[13,14]. This percentage appeared to be stable in recent
decades [15] and is significantly lower compared to people
without T2DM [13,16]. Physical activity levels might be
increased by means of an exercise intervention. Several
intervention elements are thought to increase the success
rate of such an intervention. To start with, an exercise
intervention should imply more than just education [17]. In
addition, a patient-tailored exercise plan optimises the effect
of the intervention and can increase adherence to the exer-
cise routine [18,19]. A gradual increase of physical activity
[19] can avoid injuries. Also, the use of multiple behavioural
components such as goal-setting, problem solving and feed-
back can further increase the (long-term) success of the
intervention [20]. In addition, the American College of
Sports Medicine and the American Diabetes Association
advised in their 2010 joint statement on Exercise & Dia-
betes to focus exercise interventions on self-efficacy [10].Self-efficacy is derived from the Social Cognitive Theory,
which states that a behavioural change is made possible by
a personal sense of control. Self-efficacy is one of the main
constructs of this theory and is the “belief in one’s capa-
bilities to organize and execute the courses of action
required to produce given attainments” [21]. Self-efficacy
for exercise/physical activity (exercise self-efficacy) is
believed to influence physical activity behaviour [22-24]. In
people with T2DM a high level of exercise self-efficacy is
thought to be predictive of exercise initiation and mainten-
ance over time [25], and is thought to mediate the rela-
tionship between an exercise intervention and physical
activity [26]. Also, an increased level of exercise self-
efficacy makes it more likely that participants indeed use
strategies to improve their physical activity levels [27].
A patient-tailored exercise intervention with a gradual
increase of physical activity and multiple components such
as goals setting, has the potential to increase the physical
activity level of people with T2DM. This can be provided
by means of several individual physiotherapy consultations
in which a patient tailored exercise plan is provided and
progression evaluated. Because of its important predictive
and mediating role, exercise self-efficacy has the potential
to discriminate between subjects who can be helped with
such individual physiotherapy consultations, and those
who are in need of extra support because of their low exer-
cise self-efficacy. Extra support can be given by providing
an additional group-based program. A group-based pro-
gram gives room to verbal persuasion by the physiotherap-
ist and/or group members and vicarious experiences
which are sources of self-efficacy [28] and can therefore in-
crease the level of exercise self-efficacy.
Objectives and hypotheses
The goal of this study is to evaluate a patient-tailored ex-
ercise program for people with T2DM that takes levels of
exercise self-efficacy into account. If the program suc-
ceeds in increasing the amount of physical activity it can
be implemented in regular Primary diabetes care.
The primary outcome measure of this study is physical
activity. We hypothesize that the intervention will signifi-
cantly increase the level of physical activity in the interven-
tion groups compared to the control group. In addition,
we will examine which determinants contribute to a suc-
cessful change of the amount of physical activity. Most lit-
erature seems to agree that a high age [15,16,22,29,30], low
education [15,22,30] and being female [16,22,30], are asso-
ciated with a lower level of physical activity. Although a
higher BMI seems to correlate with physical activity
among adults [22], the results of studies on people with
T2DM are conflicting [13,15,29]. In addition a low exercise
self-efficacy [22], low social support [22], a depressed
mood [31] and a type D personality [32] are thought be
determinants of a low level of physical activity. We
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being male, low BMI, a high level of exercise self-efficacy,
a high level social support, the absence of a depressed
mood and not having a type D personality contribute to a
successful change of the level of physical activity.
Secondary outcome measures are health status, (symp-
toms of) depression, exercise self-efficacy, BMI, blood pres-
sure and glycemic control.
In line with the Look AHEAD trial [33] and the DARE
study [34] we hypothesize that our intervention will signifi-
cantly improve the physical component of health status -
but not the mental component-, compared to the control
group.
In two systematic reviews [35,36] on the effects of phys-
ical activity on depressive symptoms in elderly people, it
was found that increased levels of exercise can lower
depression rates and reduce depressive symptoms in the
short term. In accordance, we therefore hypothesize that
the intervention of the current study will significantly re-
duce depressive symptoms, compared to the control group.
The intervention is thought to provide participants per-
sonal mastery experiences which is a source of self-efficacy
[28]. We therefore hypothesize that the intervention will
significantly increase exercise self-efficacy, compared to the
control group. We additionally hypothesize that the change
of exercise self-efficacy will be larger in those with low exer-
cise self-efficacy at baseline as they will receive additional
support.
Glycemic control is assessed by means of haemoglobin
A1C. As physical activity is thought to improve glycemic
control [37-39] we hypothesize that our intervention will
significantly reduce haemoglobin A1C, compared to the
control group.
Based on literature, an effect of increased physical activity
on body mass or BMI can not be expected [37,38]. We
therefore hypothesize that the intervention will not lead to
significant decrease in BMI, compared to the control group.
Literature on the effect of physical activity on blood pres-
sure is somewhat ambiguous. In the review of Thomas
et al. [37] no effect on diastolic of systolic blood pressure
was found. The American College of Sports Medicine and
American Diabetes Association concluded in their joint
statement on Exercise and Diabetes that only slight reduc-
tions of systolic blood pressure can be expected [10]. How-
ever, in a meta-analysis by Snowling et al. [40] small to
moderate effects of aerobic or a combination of aerobic and
resistance exercise on blood pressure were found. We
therefore hypothesize that the intervention of the current
study will significantly reduce systolic blood pressure in
those with an elevated blood pressure, compared to the
control group.
Finally, diabetes self-efficacy and quality of sleep are
explorative outcome measures. We therefore have no hy-
potheses regarding these outcome measures.Methods/Design
Study design
This study is conducted as a non-randomized controlled
clinical trial. Participants are allocated to three groups:
An advice intervention in which participants receive a
patient-tailored exercise intervention, an intensive inter-
vention in which participants receive a patient-tailored
exercise intervention accomplished by a group based
intervention, and a control group in which participants
receive regular Dutch diabetes care.
Eligibility
Patients are eligible when they are diagnosed with
T2DM, exercise less than advised in the ADA guideline
of 150 min/week of moderate-intensity aerobic physical
activity [12], have an BMI >25 and are between 18 and
80 years old.
Patients are excluded when they recently participated in
an exercise program on an indication other than diabetes
or suffer from a serious diabetes complication or other
disabling co-morbidity (e.g. unstable angina pectoris, heart
failure, extremely high blood pressure (systolic> 200, dia-
stolic> 120), cerebrovascular accident, serious neuropathy,
kidney failure, diabetic foot ulcer(s), proliferative retinop-
athy, a serious form of cancer, orthopaedic constraints, ser-
ious exertion hypertension, unstable coronary ischemia).
Patients with silent myocardal ischemia are also excluded.
Silent myocardial ischemia is defined as an objective docu-
mentation of myocardial ischemia in the absence of angina
or angina equivalents [41]. The prevalence of silent myocar-
dial ischemia varies from 9% up to 57% in people with
T2DM [42], and can be verified by a electrocardiogram ex-
ercise stress test.
Recruitment
Participants are recruited in rural areas surrounding the
city of Eindhoven, the Netherlands. Recruitment takes
place at a primary care organization of general practitioners
and practice nurses in the south of the Netherlands, PoZoB
(Praktijkondersteuning Zuid-oost Brabant). Eligibility is
checked by the general practitioner and/or the practice
nurse.
Allocation procedure
For practical reasons, seven areas are pointed out as
‘intervention area’. People outside these areas are invited
for the control group.
Participants of the intervention are allocated to the in-
tensive intervention or the advice intervention after fill-
ing out the baseline questionnaire. Allocation is based on
their score on the Exercise Self-efficacy Scale (ESS) that
has been developed by Bandura [43]. Since there is to
the best of our knowledge no other study that uses the
ESS to discriminate between people with T2DM in a
Table 1 Measurements and time points
Intervention group Control group
T0 T1 T2 T3 T4 T5 T0 T1 T2 T3 T4 T5
Concept (questionnaire)
Demographic variables x x
Physical activity (SQUASH) x x x x x x x x x x
Health Status (SF12) x x x x x x x x x x
Depressive symptoms
(PHQ9)
x x x x x x x x x x
Exercise self-efficacy (ESS) x x x x x x x x x x
Social support x x
Type D (DS14) x x
Diabetes self-efficacy x x x x x x x x x x
Quality of sleep x x x x x x x x x x
Patient satisfaction x x x
Clinical measurements
BMI x x x x Part of regular
diabetes care*








To - baseline; T1 - after 12 weeks; T2 - after 24 weeks; T3 - after 36 weeks
(end of intervention); T4 - after 1 year (post intervention); T5 - after 1 year and
36 weeks (post intervention); SQUASH - Short QUestionnaire to ASsess Health
enhancing physical activity; SF12 - Short Form Health Survey 12;
PHQ9 - Patient Health Questionnaire 9; ESS - Exercise self-efficacy scale;
DS14 - Type D Scale-14; * up to 4 times a year.
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ESS to split the group of intervention participants ap-
proximately in two equal halves: Participants with a
score between 0 and 40 are allocated in the intensive
intervention. Participants with a score between 41 and
100 are allocated to the advice intervention.
Intervention
The interventions’ duration is 36 weeks, with a follow-up
period of one year.
In the advice intervention (for participants with a high
exercise self-efficacy), the intervention starts with an intake
consultation with a physiotherapist. During this intake, in-
formation about the intervention and ‘Diabetes and exer-
cise’ is provided. Next, the current physical condition in
terms of aerobic power, muscle strength, blood pressure,
BMI and waist-circumference is established. Exercise toler-
ance is assessed with the six minute walk test [44]. The test
is suitable for elderly [45] and a proper reflection of activ-
ities of daily living [46]. Muscle strength is assessed with
one repetition maximum tests for the abdominal, back,
arm and leg muscles. One repetition maximum tests are a
widely spread and valid way to asses muscle strength
in vivo [47]. In addition, the goals and the exercise prefer-
ences of the participant are discussed. Subsequently, a
patient-tailored exercise plan is drafted. The exercise plan
consists of a combination of aerobic and resistance exer-
cise, replenished by balance and flexibility drills, with the
aim of exercising three hours a week, with a gradual in-
crease of intensity, difficulty and duration. When applic-
able, at-home drills are taught. An information folder with
the exercise plan, written prescription of the drills, an exer-
cise journal and information on ‘diabetes and exercise’ are
provided. Also, an information session with a dietician is
scheduled, in order to provide information on nutrition,
diabetes and exercise.
In consultations after 4, 12, 24 and 36 weeks, progres-
sion is assessed and the exercise plan is evaluated. Also,
feedback is given and possible barriers to exercise and their
conceivable solutions are discussed. If necessary, the exer-
cise plan can be adapted. In the consultations after 24 and
36 weeks, additionally, relapse prevention and the continu-
ation of exercise after the intervention are discussed.
Participants of the intensive intervention (for partici-
pants with a low exercise self-efficacy) receive a similar
intervention as do participants of the advice intervention,
but in addition they receive physiotherapist guided group
training. Groups consist of eighth participants maximally.
The 24 group trainings contain aerobic, resistance, bal-
ance, and flexibility drills. From week one up to week eight
there are two group sessions of one hour a week. From
week nine up to week sixteen there is one group session a
week. During these sixteen weeks, the participant is
expected to exercise home-based to meet up therequirements of their exercise plan. After, participants are
expected to follow up their exercise plan home-based.
Data collection
The assessments of the self-reported data take place at
baseline, at 36 weeks, at 1 year and at 1 year and
36 weeks. The intervention participants receive two add-
itional questionnaires at 12 weeks, and 24 weeks. Ques-
tionnaires will be sent out by post, along with a stamped
ballot paper envelope.
Biomedical parameters BMI, blood pressure and
haemoglobin A1C are assessed as part of regular care up
to four times a year. In addition, intervention partici-
pants will receive a BMI and blood pressure assessment
at baseline, at 12 weeks, at 24 weeks, and at 36 weeks
during their physiotherapy consultations (Table 1).
Outcome parameters
Primary outcome measure
Physical activity The level of physical activity is assessed
by means of self-report using the Short QUestionnaire to
ASsess Health enhancing physical activity (SQUASH).
This questionnaire has been proved to be a reliable and
valid measurement in adults [48]. Participants are asked to
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week in the past month, with regard to activity at work
(if applicable), commuting activities (if applicable), house-
hold activities (if applicable), and leisure time. The fre-
quency of activities (days/week), as well as the duration
(average time/day) and experienced intensity of these
activities (light, moderate, vigorous), are measured. Each
activity is represented by a metabolic equivalent (MET).
MET expresses the cost of energy from physical activities
as multiples of the resting metabolic rate. Activities can be
divided into three categories of intensity based on their
MET: light (2 to <4.0 METs), moderate (4.0 to <6.5
METs) and vigorous (≥ 6.5 METs) intensity [48].
Secondary outcome measures
Health status Health status is assessed using the Short
Form Health Survey 12 (SF12), a shortened version of
the Short Form Health Survey 36 [49]. The SF12 is a
self-reported questionnaire and consists of twelve items
with two component summary scores: physical health
(PCS) and mental health (MCS). Both components are
scored on a scale from 0 to 100, with a higher score
representing a better health status [50].
Depressive symptoms Depressive symptoms are assessed
with the self-reported Patient Health Questionnaire 9
(PHQ9). The questionnaire contains nine items derived
from the Diagnostic and Statistical Manual of Mental
Disorders, Fourth Edition (DSM-IV), related to the past
two weeks. The items are scored on a four point scale,
ranging from 0 (not at all) to 3 (almost every day) [51].
Exercise self-efficacy Exercise self-efficacy is assessed
with the ESS [43]. This self-reported questionnaire contains
eighteen items that describe situations during which it
could be difficult to adhere to an exercise routine, for ex-
ample: “when I am feeling tired” or “during bad weather”.
Participants are asked to rate their degree of confidence to
continue with regular exercise in the listed situations. The
ESS uses a 100-point scale for each item, ranging from 0 (“I
cannot do this at all”) to 100 (“I am certain that I can do
it”), the higher scores reflecting higher levels of exercise
self-efficacy. The total ESS score is calculated as the mean
of all the items. The ESS appeared to have a single factor
solution [52,53]. The questionnaire is positively correlated
with the frequency of exercise [52], has no floor or ceiling
effects, good internal consistency with an Cronbachs α coef-
ficient of 0,95 and has good responsiveness to change [53].
Since a relatively high percentage of people with
T2DM are retired, the original item “When I am feeling
under pressure from work” is in the current study
adapted to “When I am feeling under pressure”.
BMI, blood pressure and hemoglobin A1C Biomedical
parameters (laboratory tests and physical examination)
are assessed as part of regular care up to four times a
year and performed by the Diagnostic Centre in (areassurrounding the city of ) Eindhoven, the Netherlands. To
assess glycemic control we retrieve data from their files
on haemoglobin A1C. In addition, data on BMI and
blood pressure (systolic and diastolic) are retrieved from
the files. Participants of the intervention receive add-
itional BMI and blood pressure measurements as part of
the physiotherapist consultations.
Explorative outcome measures
Diabetes self-efficacy Twelve self-reported items are
used to quantify diabetes self-efficacy. The participants
are asked to rate their level of confidence to execute dia-
betes self-care behaviours. The items are scored on a six-
point likert scale, from 0 (‘totally disagree’) to 5 (‘totally
agree’) and concern ‘prevention of high blood sugars’,
‘healthy diet’, ‘avoid/reduce obesity’, ‘proper use of medica-
tion’, ‘enough exercise’, ‘no smoking’, ‘no alcohol’, ‘ask for
help when necessary’, ‘follow up appointments with care-
givers’, ‘follow up life-style advice in special situations’,
‘ask for clarification regarding T2DM when things are
unclear’ and ‘accepting T2DM’.
Quality of sleep Thirteen self-reported items assess vari-
ous aspects of quality of sleep, related to the past week.
The items concern the length of sleep, difficulty of getting
to sleep or staying a sleep, overall quality of sleep, resting
during the day, sleeping during the day, difficulty staying
awake during the day and sleep-related medications.
Additional measures
Demographic and clinical variables Age, gender, na-
tionality, marital status, living arrangements, education,
work situation, smoking behaviour, alcohol behaviour
and year of diabetes diagnosis are assessed by means of a
self-reported questionnaire at baseline. Co-morbidities,
medication and diabetes treatment (diet and/or tablets
and/or insulin) are retrieved from (electronic) medical
records when possible.
Social support Social support not only has a main effect
on the level of physical activity, a study with older adults
with multiple illnesses showed that social support also has
a synergistic effect with exercise self-efficacy [54]. Social
support is measured by four questions that are rated on a
five point scale (0=no support, 4 =much support).
Type D personality People with a Type D personality
have a general tendency towards increased negative
affectivity and inhibit these emotions in social situations.
People with a type D personality adhere less to the physical
activity norm [32].
Type D personality is measured by the Type D Scale-
14 (DS14). The DS14 comprises fourteen items and is
scored on a five point scale (0 = false, 4 = correct). The
DS14 consists of two subscales for which sum scores are
calculated: negative affectivity and social inhibition. Both
scales are internally consistent (Cronbachs α coefficient
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mood and health [55].
Patient satisfaction Participants of the intervention are
asked to rate their satisfaction with treatment by means
of a self-report questionnaire regarding the organization
of the intervention, supervision of the physiotherapist
and the content of the intervention. In addition, it is
assessed whether the participant intends to continue the
level of physical activity after the intervention.Statistical analyses
Sample size and power calculation
The intervention of this study consists of two groups (an in-
tensive group and an advice group) to which participants
are allocated based on their exercise self-efficacy score.
Therefore, for analyses, the control group participants will
also be allocated to a low exercise self-efficacy control group
(ESS ≤40) and a high exercise self-efficacy control group
(ESS >40).
Fisher’s exact test was used to calculate the number of
subjects that have to be included in this study. We ex-
pect 50% of the intervention participants and 25% of the
control group participants to meet up with the require-
ment of 150 minutes a week of moderate intensity phys-
ical activity at the end of the intervention (36 weeks).
Taken into account a power of 0.9, an alpha of 0.05, an
expected drop-out rate of 25% in the intervention and
50% in the control group, 94 participants need to be
included in the intensive intervention group, 94 partici-
pants in the advice intervention group, 142 participants
in the high exercise self-efficacy control group, and 142
participants in the low exercise self-efficacy control
group. To be able to perform cross-validation and per-
form analysis in (equally sized) subgroups, an inclusion
of 366 participants in the intervention and 586 partici-
pants in the control group is desirable.Planned analyses
Analyses will be performed using the latest version of the
Social Package for Social Sciences (IBM, Chicago, Illinois,
USA). Assumptions for parametric analyses will be
checked for all analysis, and tests will be performed with a
significance level of 5%. Differences in patient characteris-
tics between groups will be checked be means of T-tests
and X2 tests, or there non-parametric equivalents.
Repeated measures analysis of variance and multilevel
analysis for longitudinal data will be used to examine
longitudinal differences between groups on primary and
secondary outcome measures. To test which determi-
nants contribute to a successful change in the level of
physical activity, linear/logistic regression analyses will
be used. Participants will be analysed within the group to
which they were allocated.Ethical principles
The study protocol has been approved by the medical
ethical committee of the St. Elisabeth Hospital, Tilburg,
the Netherlands. Written consent will be obtained from
all participants.
Discussion
The number of people with T2DM is rapidly rising up to
366 million in 2030 [56]. As physical activity can -
among other things- improve glycemic control, people
with T2DM are advised to have at least 150 min/week of
moderate-intensity aerobic physical activity [12]. Unfor-
tunately only 30-40% of people with T2DM are suffi-
ciently active [13,14]. An important predictor of exercise
initiation and maintenance in people with T2DM, is ex-
ercise self-efficacy [25]. We therefore designed a patient-
tailored intervention that aims to increase the level of
physical activity of the participants, in which extra sup-
port is given to those with the lowest exercise self-
efficacy.
In this study we aim not only to design an intervention
that can directly be implemented in primary care, but
also to design an easy accessible program. We chose to
use a multi-centre approach with seven physiotherapist
practices, so that participants’ travelling time is mini-
mized. This approach also allows participants to meet
other participants from the neighbourhood, which might
stimulate the continuation of exercise after the interven-
tion. Also, the physical condition and preferences of the
participants are taken into account in the patient-tailored
exercise plan. As a result the exercise plan is suitable for
the participant, the risk of injuries is minimized, and ad-
herence might be increased.
This study has several strengths. First, this study is in-
novative as it is -to the best of our knowledge- the first
study that takes levels of exercise self-efficacy of people
with T2DM into account, giving extra support to those
with the lowest exercise self-efficacy. Secondly, the large
number of participants that will be included. As the
intervention is embedded in regular diabetes care, we are
confident that we will be able to include the required
number of participants. Thirdly, as a large portion of the
studies on physical activity in people with T2DM focuses
on clinical outcomes, we also included psychosocial out-
comes such as perceived health status and depressive
symptoms. Finally, this study focuses on primary care
patients. Primary care patients tend to have less severe
co-morbidities compared to secondary care patients, so
prevention of future co-morbidities might be possible.
Several limitations of the design of this study also need
to be addressed. This study is not randomised. This may
lower the validity of our findings. However, by using a
matched control group (age and gender) and correcting
for baseline differences, we will try to minimize the
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tion is the determination of the ESS cut-off point for par-
ticipant allocation, as it is based on a median score. It is
possible that post hoc analysis might suggest that other
cut-off points should have been used. Also, glycemic con-
trol will be measured only as part of regular diabetes care,
as are BMI and blood pressure for the control group parti-
cipants. As a consequence, the measurement time points
of the questionnaires may not correspond with these la-
boratory assessments. However, BMI and haemoglobin
A1C are rather stable biological markers of T2DM and we
aimed to design an easy accessible intervention, which
includes minimization of the participants’ burden. Finally,
for practical reasons the measurement of physical activity
is by means of self-report. Self-reported physical activity
tends to result in an overestimation of levels of activity
and different activity patterns compared to more objective
estimates [57]. Yet, the SQUASH shows moderate correla-
tions with data from accelerometer measurements [48].
Conclusion
In conclusion, the need to increase the level of physical
activity in people with T2DM is evident, in which exercise
self-efficacy can play an important role. In the present study
we will evaluate a patient-tailored exercise program for
people with T2DM that takes levels of exercise self-efficacy
into account.
Competing interests
The authors declare that they have no competing interests.
Acknowledgements
This study was financially supported by CZ Health Insurance. We thank
PoZoB for their participation.
Author details
1Department of Medical Psychology and Neuropsychology, Center of
Research on Psychology in Somatic diseases (CoRPS), Tilburg University,
Tilburg, the Netherlands. 2PoZoB, Coordination Centre of Practice Nurses for
South East Netherlands, Veldhoven, the Netherlands.
Authors’ contributions
All authors contributed to the design of the study. VP is the principal
investigator of the study. MH drafted the manuscript. FP, AR and VP
reviewed/edited the manuscript. All authors approved the various versions
including the final version of the manuscript.
Received: 16 March 2012 Accepted: 4 May 2012
Published: 4 May 2012
References
1. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes
mellitus and its complications. Part 1: diagnosis and classification of
diabetes mellitus provisional report of a WHO consultation. Diabet Med
1998, 15(7):539–553.
2. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes:
estimates for the year 2000 and projections for 2030. Diabetes Care 2004,
27(5):1047–1053.
3. Fact sheet No 312 Diabetes http://www.who.int/mediacentre/factsheets/
fs312/en/.
4. Williams R, Van Gaal L, Lucioni C: Assessing the impact of complications
on the costs of Type II diabetes. Diabetologia 2002, 45(7):S13–S17.5. Roglic G, Unwin N, Bennett PH, Mathers C, Tuomilehto J, Nag S, Connolly V,
King H: The burden of mortality attributable to diabetes: realistic
estimates for the year 2000. Diabetes Care 2005, 28(9):2130–2135.
6. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, Willett WC:
Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J
Med 2001, 345(11):790–797.
7. Hu G, Lindstrom J, Valle TT, Eriksson JG, Jousilahti P, Silventoinen K, Qiao Q,
Tuomilehto J: Physical activity, body mass index, and risk of type 2
diabetes in patients with normal or impaired glucose regulation. Arch
Intern Med 2004, 164(8):892–896.
8. Sullivan PW, Morrato EH, Ghushchyan V, Wyatt HR, Hill JO: Obesity,
inactivity, and the prevalence of diabetes and diabetes-related
cardiovascular comorbidities in the U.S., 2000–2002. Diabetes Care 2005,
28(7):1599–1603.
9. Marwick TH, Hordern MD, Miller T, Chyun DA, Bertoni AG, Blumenthal RS,
Philippides G, Rocchini A: Exercise training for type 2 diabetes mellitus:
impact on cardiovascular risk: a scientific statement from the American
Heart Association. Circulation 2009, 119(25):3244–3262.
10. American College of Sports Medicine and the American Diabetes
Association: Exercise and type 2 diabetes: American College of Sports
Medicine and the American Diabetes Association: joint position
statement. Med Sci Sports Exerc 2010, 42(12):2282–2303.
11. Hu G, Jousilahti P, Barengo NC, Qiao Q, Lakka TA, Tuomilehto J: Physical
activity, cardiovascular risk factors, and mortality among Finnish adults
with diabetes. Diabetes Care 2005, 28(4):799–805.
12. Association AD: Standards of medical care in diabetes–2011. Diabetes Care
2011, 34(Suppl 1):S11–S61.
13. Morrato EH, Hill JO, Wyatt HR, Ghushchyan V, Sullivan PW: Physical activity
in U.S. adults with diabetes and at risk for developing diabetes, 2003.
Diabetes Care 2007, 30(2):203–209.
14. Plotnikoff RC, Johnson ST, Loucaides CA, Bauman AE, Karunamuni ND,
Pickering MA: Population-based estimates of physical activity for adults
with type 2 diabetes: a cautionary tale of potential confounding by
weight status. J Obes 2011, 2011. doi: 10.1155/2011/561432.
15. Zhao G, Ford ES, Li C, Mokdad AH: Compliance with physical activity
recommendations in US adults with diabetes. Diabet Med 2008, 25(2):221–227.
16. Zhao G, Ford ES, Li C, Balluz LS: Physical activity in u.s. Older adults with
diabetes mellitus: prevalence and correlates of meeting physical activity
recommendations. J Am Geriatr Soc 2011, 59(1):132–137.
17. Marcus BH, Williams DM, Dubbert PM, Sallis JF, King AC, Yancey AK, Franklin
BA, Buchner D, Daniels SR, Claytor RP: Physical activity intervention
studies: what we know and what we need to know: a scientific
statement from the American Heart Association Council on Nutrition,
Physical Activity, and Metabolism (Subcommittee on Physical Activity);
Council on Cardiovascular Disease in the Young; and the Interdisciplinary
Working Group on Quality of Care and Outcomes Research. Circulation
2006, 114(24):2739–2752.
18. Kahn EB, Ramsey LT, Brownson RC, Heath GW, Howze EH, Powell KE, Stone EJ,
Rajab MW, Corso P: The effectiveness of interventions to increase physical
activity. A systematic review. Am J Prev Med 2002, 22(4 Suppl):73–107.
19. Praet SF, van Loon LJ: Optimizing the therapeutic benefits of exercise in
Type 2 diabetes. J Appl Physiol 2007, 103(4):1113–1120.
20. Simons-Morton DG, Calfas KJ, Oldenburg B, Burton NW: Effects of
interventions in health care settings on physical activity or
cardiorespiratory fitness. Am J Prev Med 1998, 15(4):413–430.
21. Bandura A: Self-efficacy: the exercise of control. New York: Freeman; 1997.
22. Trost SG, Owen N, Bauman AE, Sallis JF, Brown W: Correlates of adults’
participation in physical activity: review and update. Med Sci Sports Exerc
2002, 34(12):1996–2001.
23. Delahanty LM, Conroy MB, Nathan DM: Psychological predictors of physical
activity in the diabetes prevention program. J Am Diet Assoc 2006, 106(5):698–705.
24. McAuley E, Jerome GJ, Elavsky S, Marquez DX, Ramsey SN: Predicting long-term
maintenance of physical activity in older adults. Prev Med 2003, 37(2):110–118.
25. Allen NA: Social cognitive theory in diabetes exercise research: an
integrative literature review. Diabetes Educ 2004, 30(5):805–819.
26. Dutton GR, Tan F, Provost BC, Sorenson JL, Allen B, Smith D: Relationship
between self-efficacy and physical activity among patients with type 2
diabetes. J Behav Med 2009, 32(3):270–277.
27. Anderson ES, Winett RA, Wojcik JR, Williams DM: Social cognitive mediators
of change in a group randomized nutrition and physical activity
intervention: social support, self-efficacy, outcome expectations and self-
regulation in the guide-to-health trial. J Health Psychol 2010, 15(1):21–32.
van der Heijden et al. BMC Public Health 2012, 12:331 Page 8 of 8
http://www.biomedcentral.com/1471-2458/12/33128. Bandura A: Self-efficacy: toward a unifying theory of behavioral change.
Psychol Rev 1977, 84(2):191–215.
29. Nelson KM, Reiber G, Boyko EJ: Diet and exercise among adults with type
2 diabetes: findings from the third national health and nutrition
examination survey (NHANES III). Diabetes Care 2002, 25(10):1722–1728.
30. Plotnikoff RC, Taylor LM, Wilson PM, Courneya KS, Sigal RJ, Birkett N, Raine K,
Svenson LW: Factors associated with physical activity in Canadian adults
with diabetes. Med Sci Sports Exerc 2006, 38(8):1526–1534.
31. Lysy Z, Da Costa D, Dasgupta K: The association of physical activity and
depression in Type 2 diabetes. Diabet Med 2008, 25(10):1133–1141.
32. Mommersteeg PM, Kupper N, Denollet J: Type D personality is associated
with increased metabolic syndrome prevalence and an unhealthy
lifestyle in a cross-sectional Dutch community sample. BMC Publ Health
2010, 10:714.
33. Williamson DA, Rejeski J, Lang W, Van Dorsten B, Fabricatore AN, Toledo K:
Impact of a weight management program on health-related quality of
life in overweight adults with type 2 diabetes. Arch Intern Med 2009, 169
(2):163–171.
34. Reid RD, Tulloch HE, Sigal RJ, Kenny GP, Fortier M, McDonnell L, Wells GA,
Boule NG, Phillips P, Coyle D: Effects of aerobic exercise, resistance
exercise or both, on patient-reported health status and well-being in
type 2 diabetes mellitus: a randomised trial. Diabetologia 2010,
53(4):632–640.
35. Blake H, Mo P, Malik S, Thomas S: How effective are physical activity
interventions for alleviating depressive symptoms in older people? A
systematic review. Clin Rehabil 2009, 23(10):873–887.
36. Sjosten N, Kivela SL: The effects of physical exercise on depressive
symptoms among the aged: a systematic review. Int J Geriatr Psychiatry
2006, 21(5):410–418.
37. Thomas DE, Elliott EJ, Naughton GA: Exercise for type 2 diabetes mellitus.
Cochrane Database Syst Rev 2006, 3:CD002968.
38. Boule NG, Haddad E, Kenny GP, Wells GA, Sigal RJ: Effects of exercise on
glycemic control and body mass in type 2 diabetes mellitus: a meta-
analysis of controlled clinical trials. JAMA 2001, 286(10):1218–1227.
39. Umpierre D, Ribeiro PAB, Kramer CK: Physical activity advice only or
structured exercise training and association with Hba1c levels in type 2
diabetes. A systematic review and meta-analysis. JAMA 2011, 305
(17):1790–1799.
40. Snowling NJ, Hopkins WG: Effects of different modes of exercise training
on glucose control and risk factors for complications in type 2 diabetic
patients: a meta-analysis. Diabetes Care 2006, 29(11):2518–2527.
41. Cohn PF, Fox KM, Daly C: Silent myocardial ischemia. Circulation 2003, 108
(10):1263–1277.
42. Janand-Delenne B, Savin B, Habib G, Bory M, Vague P, Lassmann-Vague V:
Silent myocardial ischemia in patients with diabetes: who to screen.
Diabetes Care 1999, 22(9):1396–1400.
43. Bandura A: Guide for constructing self-efficacy scales. In Self-efficacy beliefs
of adolescents. edn. Edited by Pajares F, Urdan T. Greenwich: Information
Age Publishing; 2006:307–337.
44. Butland RJ, Pang J, Gross ER, Woodcock AA, Geddes DM: Two-, six-, and 12-
minute walking tests in respiratory disease. Br Med J (Clin Res Ed) 1982,
284(6329):1607–1608.
45. Enright PL, McBurnie MA, Bittner V, Tracy RP, McNamara R, Arnold A,
Newman AB: The 6-min walk test: a quick measure of functional status in
elderly adults. Chest 2003, 123(2):387–398.
46. Solway S, Brooks D, Lacasse Y, Thomas S: A qualitative systematic overview
of the measurement properties of functional walk tests used in the
cardiorespiratory domain. Chest 2001, 119(1):256–270.
47. Verdijk LB, van Loon L, Meijer K, Savelberg HH: One-repetition maximum
strength test represents a valid means to assess leg strength in vivo in
humans. J Sports Sci 2009, 27(1):59–68.
48. Wendel-Vos GC, Schuit AJ, Saris WH, Kromhout D: Reproducibility and
relative validity of the Short QUestionnaire to ASsess Health-enhancing
physical activity. J Clin Epidemiol 2003, 56(12):1163–1169.
49. Wee CC, Davis RB, Hamel MB: Comparing the SF-12 and SF-36 health
status questionnaires in patients with and without obesity. Health Qual
Life Outcomes 2008, 6:11.
50. Ware J Jr, Kosinski M, Keller SD: A 12-Item Short-Form Health Survey:
construction of scales and preliminary tests of reliability and validity. Med
Care 1996, 34(3):220–233.51. Spitzer RL, Kroenke K, Williams JB: Validation and utility of a self-report
version of PRIME-MD: the PHQ primary care study. Primary Care
Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999,
282(18):1737–1744.
52. Shin Y, Jang H, Pender NJ: Psychometric evaluation of the exercise self-
efficacy scale among Korean adults with chronic diseases. Res Nurs Health
2001, 24(1):68–76.
53. Everett B, Salamonson Y, Davidson PM: Bandura’s exercise self-efficacy
scale: validation in an Australian cardiac rehabilitation setting. Int J Nurs
Stud 2009, 46(6):824–829.
54. Warner LM, Ziegelmann JP, Schuz B, Wurm S, Schwarzer R: Synergistic
effect of social support and self-efficacy on physical exercise in older
adults. J Aging Phys Act 2011, 19(3):249–261.
55. Denollet J: DS14: standard assessment of negative affectivity, social
inhibition, and Type D personality. Psychosom Med 2005, 67(1):89–97.
56. WHO: Definition, diagnosis and classification of Diabetes Mellitus and it’s
complications. In Report of a WHO consultation. Part 1. Geneva: World
Health Organisation; 1999:1–59.
57. Hagstromer M, Oja P, Sjostrom M: Physical activity and inactivity in an
adult population assessed by accelerometry. Med Sci Sports Exerc 2007, 39
(9):1502–1508.
doi:10.1186/1471-2458-12-331
Cite this article as: van der Heijden et al.: Testing the effectiveness of a
self-efficacy based exercise intervention for inactive people with type 2
diabetes mellitus: design of a controlled clinical trial. BMC Public Health
2012 12:331.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
